Matches in Nanopublications for { ?s ?p "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP264553.RACfQZGSwJKyrIUfPilDoRqJkdvUydLsHFiVkFwtSlUVE130_assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264553.RACfQZGSwJKyrIUfPilDoRqJkdvUydLsHFiVkFwtSlUVE130_provenance.
- assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP937288.RAYKvXQi0bTKLg943ofh27JPsNrecL2u4tTkx681K7qlI130_assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937288.RAYKvXQi0bTKLg943ofh27JPsNrecL2u4tTkx681K7qlI130_provenance.
- NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_provenance.
- NP580526.RAsH-mg7EjOBtFuB4WhepbTjGn6Ki7PkNCMELnyhYkhAg130_assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580526.RAsH-mg7EjOBtFuB4WhepbTjGn6Ki7PkNCMELnyhYkhAg130_provenance.
- NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_provenance.